Bruker (BRKR) Non-Current Receivables (2023 - 2025)

Bruker (BRKR) has 3 years of Non-Current Receivables data on file, last reported at $102.9 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Receivables rose 24.73% year-over-year to $102.9 million; the trailing twelve-month figure through Dec 2025 stood at $102.9 million (up 24.73% YoY), and the FY2025 full-year result was $102.9 million, up 24.73% from the prior year.
• Non-Current Receivables for Q4 2025 stood at $102.9 million, up from $82.5 million in the prior quarter.
• Across five years, Non-Current Receivables topped out at $102.9 million in Q4 2025 and bottomed at $77.2 million in Q4 2023.
• The 3-year median for Non-Current Receivables is $82.5 million (2024), against an average of $87.5 million.
• The widest annual swing landed in 2024, when Non-Current Receivables grew 6.87%; it then climbed 24.73% in 2025.
• A 3-year view of Non-Current Receivables shows it stood at $77.2 million in 2023, then increased by 6.87% to $82.5 million in 2024, then rose by 24.73% to $102.9 million in 2025.
• The last three Non-Current Receivables figures came in at $102.9 million (Q4 2025), $82.5 million (Q4 2024), and $77.2 million (Q4 2023), per Business Quant data.

Peer Comparison